Intellipharmaceutics International Inc. (IPCI)

[fabius]

Wimus,
I tend to agree that expectations about an approval (tentative) should be very low.

That's way I am screaming at the company to do something (strategic) BEFORE the PDUFA date. My biggest fear is that Odidi will be 100% on the Rexista required studies, instead of moving in parallel with other strategic options, come of which we know being MUCH bigger than Rexista.

if this happens, when FDA doesn't approve we are going to be crashed by another 50% free fall. it really seems to me Odidi took the wrong path when he decided to be a listed companies.
I sound pessimistic, but I am still holding long here, hoping for a new fresh change in the company strategic directions.